Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Elizabeth A. Raetz(NYU Langone Health), William L. Carroll(NYU Langone Health), Naomi Winick(The University of Texas Southwestern Medical Center), Meenakshi Devidas(National Institutes of Health), Michael J. Borowitz(Johns Hopkins University), Stephen B. Linda(Children's Hospital of Wisconsin), Stephen P. Hunger(Children's Hospital of Philadelphia), Bruce M. Camitta(Medical College of Wisconsin), Paul S. Gaynon(University of Southern California)
Cited by 219
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|1.2k